A. Maeda

发表

Application of water-insoluble polymers to orally disintegrating tablets treated by high-pressure carbon dioxide gas.

Yoshitaka Ito, S. Itai, Y. Iwao, 2016, International journal of pharmaceutics.

Mechanism of controlled drug release from a salting-out taste-masking system.

T. Uchida, Takayuki Yoshida, K. Sako, 2008, Journal of controlled release : official journal of the Controlled Release Society.

In vivo fate of folate-BSA in non-tumor- and tumor-bearing mice.

S. Kagatani, T. Shinoda, Y. Konno, 1998, Journal of pharmaceutical sciences.

Enhanced pharmacological activity of recombinant human interleukin-11 (rhIL11) by chemical modification with polyethylene glycol.

M. Hashida, Y. Takakura, T. Yoshioka, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Formulation Design and Evaluation of Liposomal Sepantronium Bromide (YM155), a Small-Molecule Survivin Suppressant, Based on Pharmacokinetic Modeling and Simulation

N. Oku, K. Sako, A. Maeda, 2014, Pharmaceutical Research.

Specific interaction between galactose branched-cyclodextrins and hepatocytes in vitro

S. Kagatani, T. Shinoda, Y. Konno, 1998 .

Salting-out taste-masking system generates lag time with subsequent immediate release.

T. Uchida, K. Sako, A. Maeda, 2009, International journal of pharmaceutics.

Sugar-branched-cyclodextrins as injectable drug carriers in mice.

S. Kagatani, T. Shinoda, Y. Konno, 1999, Drug development and industrial pharmacy.

Effects of physicochemical properties of salting-out layer components on drug release.

Takayuki Yoshida, K. Sako, A. Maeda, 2009, International journal of pharmaceutics.

Evaluating tamsulosin hydrochloride-released microparticles prepared using single-step matrix coating.

T. Shinoda, N. Oku, A. Maeda, 2011, International journal of pharmaceutics.

Specific Interaction with Hepatocytes and Acute Toxicity of New Carrier Molecule Galactosyl-Polylysine

S. Kagatani, T. Shinoda, Y. Konno, 1999 .

Antitumor efficacy and biodistribution of liposomal sepantronium bromide (YM155), a novel small-molecule survivin suppressant.

N. Oku, K. Sako, A. Maeda, 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Absorption improvement of sepantronium bromide (YM155) by aminoalkyl methacrylate copolymers in in situ intestinal tracts of mice

S. Yamada, Y. Kagawa, K. Sako, 2015 .

Nanosphere Coated with Lactosyl-Polystyrene Polymer as a Targeting Carrier to Hepatocytes

S. Kagatani, T. Shinoda, Y. Konno, 1999 .

Oral tacrolimus oil formulations for enhanced lymphatic delivery and efficient inhibition of T-cell's interleukin-2 production.

Takayuki Yoshida, K. Sako, T. Yoshioka, 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Optimization of salting-out taste-masking system for micro-beads containing drugs with high solubility.

T. Uchida, Takayuki Yoshida, K. Sako, 2008, Chemical & pharmaceutical bulletin.

Incorporation into a biodegradable hyaluronic acid matrix enhances in vivo efficacy of recombinant human interleukin 11 (rhIL11).

M. Hashida, Y. Takakura, T. Yoshioka, 2006, Journal of controlled release : official journal of the Controlled Release Society.

Salting-out taste-masking system generates lag time with subsequent immediate release.

A. Maeda, Masataka Katsuma, Takatsune Yoshida, 2009, International journal of pharmaceutics.